Real-time enrollment status for this angioimmunoblastic t-cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 19, 2026 at 7:43 PM UTC
| NCT Number | NCT04803201 |
| Recruiting Status | Recruiting |
| Condition | Angioimmunoblastic T-cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 170 participants |
| Active Locations | 96 sites in the US |
| Sponsor | Alliance for Clinical Trials in Oncology |
| Last Updated on CT.gov | August 19, 2026 (19 hours ago) |
As of August 19, 2026: Clinical trial NCT04803201 is currently recruiting participants. This phase2 study for angioimmunoblastic t-cell lymphoma is actively seeking new participants at 96 locations across the United States. The study is sponsored by Alliance for Clinical Trials in Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04803201 is actively recruiting participants as of August 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 96 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04803201 was last updated 19 hours ago (August 19, 2026). HelloStudys verifies this status automatically.